Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2021.04.12.21255324: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Field Sample Permit: We collected serum samples from each participant and quantified SARS-CoV-2 S-RBD antibodies by ELISAs within 36-48 hours after sample collection.
Consent: Informed consent was collected from all participants prior to the baseline visit.
IRB: This study was approved by the Institutional Review Board of the University of Pennsylvania under IRB #842847.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources We collected NP swabs from all health care workers who possessed SARS-CoV-2 S-RBD IgG and/or IgM antibodies and we completed … SciScore for 10.1101/2021.04.12.21255324: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Field Sample Permit: We collected serum samples from each participant and quantified SARS-CoV-2 S-RBD antibodies by ELISAs within 36-48 hours after sample collection.
Consent: Informed consent was collected from all participants prior to the baseline visit.
IRB: This study was approved by the Institutional Review Board of the University of Pennsylvania under IRB #842847.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources We collected NP swabs from all health care workers who possessed SARS-CoV-2 S-RBD IgG and/or IgM antibodies and we completed SARS-CoV-2 PCR testing on these samples to identify active or recent infections. IgMsuggested: NoneEnzyme-linked immunosorbent assay (ELISA): ELISAs measuring antibodies against SARS-CoV-2 and against OC43, HKU1, 229E and NL63 were completed as previously described (13). OC43suggested: (Virostat Cat# 3879, RRID:AB_2889994)HKU1suggested: NoneAfter 2 hours of incubation, plates were washed with PBS-T and 50 μL of 1:5,000 diluted goat anti-human IgG-HRP (Jackson ImmunoResearch Laboratories) or 1:1,000 diluted goat anti-human IgM-HRP (SouthernBiotech) was added to each well. anti-human IgG-HRPsuggested: NonePlasmids to express the CR3022 monoclonal antibody were provided by Ian Wilson (Scripps). CR3022suggested: NoneSARS-CoV-2 S-RBD antibody concentrations below this cutoff at 0.48 arbitrary units/mL were assigned a value of 0.40 arbitrary units/mL. SARS-CoV-2 S-RBDsuggested: NoneExperimental Models: Cell Lines Sentences Resources SARS-CoV-2 S-FL and S-RBD were produced in 293F cells and purified using Ni-NTA (Qiagen). 293Fsuggested: RRID:CVCL_D615)Software and Algorithms Sentences Resources Prism version 9 (GraphPad) and R version 3.5.3 were used for analyses. GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-